A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Area of Science:

• Endocrinology
• Cell Biology
• Drug Discovery

Background:

• Loss of insulin-producing beta-cells is central to diabetes pathogenesis.
• Endogenous beta-cell regeneration is a promising therapeutic strategy.
• Understanding molecular pathways restraining beta-cell growth is critical.

Purpose of the Study:

• To develop and validate an automated high-content screening assay for identifying small molecules that promote pancreatic beta-cell replication.
• To overcome limitations of previous methods, such as reliance on immortalized cell lines and inconsistent primary cell quality.

Main Methods:

• Utilized primary islet cells in a 384-well format for high-throughput screening.
• Optimized isolation, dispersion, plating, and culture parameters to minimize variability.
• Employed automated immunostaining, data acquisition, and analysis to accurately measure low basal beta-cell replication rates.

Main Results:

• Successfully established a robust, automated screening method for primary islet cells.
• Identified small molecules capable of promoting beta-cell replication.
• Demonstrated the assay's suitability for studying mitogenic effects and regulatory mechanisms of beta-cell growth.

Conclusions:

• The developed automated screening assay effectively identifies beta-cell replication-promoting compounds.
• This method overcomes key limitations of prior techniques, enhancing reliability and throughput.
• The assay is adaptable for human islet studies and crucial for advancing diabetes therapeutics.